BCL2; | |
P4HB; AKR1B1; | |
BACE1; |
Cytochrome P450 Enzymes: |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Aspartic protease | BACE1 | Beta-secretase 1 | P56817 | CHEMBL4822 |
Enzyme_unclassified | P4HB | Protein disulfide-isomerase | P07237 | CHEMBL5422 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Miscellaneous ion channel | BCL2 | Apoptosis regulator Bcl-2 | P10415 | CHEMBL4860 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0006979; response to oxidative stress | 2.191E-05 | 3.006E-01 | AKR1B1, BCL2, P4HB |
BP | GO:0008152; metabolic process | GO:0018958; phenol-containing compound metabolic process | 9.608E-05 | 3.006E-01 | AKR1B1, BCL2 |
BP | GO:0032501; multicellular organismal process | GO:0003014; renal system process | 1.457E-04 | 3.006E-01 | AKR1B1, BCL2 |
BP | GO:0009987; cellular process | GO:0071456; cellular response to hypoxia | 1.711E-04 | 3.006E-01 | BCL2, P4HB |
BP | GO:0050896; response to stimulus | GO:0042542; response to hydrogen peroxide | 1.845E-04 | 3.006E-01 | AKR1B1, BCL2 |
MF | GO:0005488; binding | GO:0051434; BH3 domain binding | 1.035E-03 | 4.691E-01 | BCL2 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09120 Genetic Information Processing | 09123 Folding, sorting and degradation | hsa04141 | Protein processing in endoplasmic reticulum | 4.212E-04 | 1.179E-02 | BCL2, P4HB |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 5.987E-03 | 4.163E-02 | AKR1B1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00051 | Fructose and mannose metabolism | 6.385E-03 | 4.163E-02 | AKR1B1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00561 | Glycerolipid metabolism | 1.175E-02 | 4.163E-02 | AKR1B1 |
09160 Human Diseases | 09161 Cancers | hsa05210 | Colorectal cancer | 1.234E-02 | 4.163E-02 | BCL2 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05014 | Amyotrophic lateral sclerosis (ALS) | 1.016E-02 | 4.163E-02 | BCL2 |
09160 Human Diseases | 09161 Cancers | hsa05215 | Prostate cancer | 1.768E-02 | 4.163E-02 | BCL2 |
09160 Human Diseases | 09166 Endocrine and metabolic diseases | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.005E-02 | 4.163E-02 | BCL2 |
09160 Human Diseases | 09161 Cancers | hsa05222 | Small cell lung cancer | 1.709E-02 | 4.163E-02 | BCL2 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04071 | Sphingolipid signaling pathway | 2.379E-02 | 4.163E-02 | BCL2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Lymphoma | C81-C86 | BCL2; |
C00-D49: Neoplasms | Leukemia | C90-C95 | BCL2; |
G00-G99: Diseases of the nervous system G00-G99 | Amyotrophic lateral sclerosis | G12.2 | BCL2; |
C00-D49: Neoplasms | Multiple myeloma | C90 | BCL2; |
C00-D49: Neoplasms | Advanced melanoma | C43 | BCL2; |
C00-D49: Neoplasms | Prostate cancer | C61 | BCL2; |
C00-D49: Neoplasms | Cancer | C00-C96 | BCL2; |
C00-D49: Neoplasms | Breast cancer | C50 | BCL2; |
C00-D49: Neoplasms | Chronic lymphocytic leukaemia | C91 | BCL2; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | BCL2; |